SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001038133-23-000023
Filing Date
2023-05-05
Accepted
2023-05-05 12:50:39
Documents
89
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hska-20230331.htm   iXBRL 10-Q 1805176
2 EX-31.1 heska-03312023xex31x1.htm EX-31.1 11044
3 EX-31.2 heska-03312023xexx31x2.htm EX-31.2 10982
4 EX-32.1 heska-03312023xex32x1.htm EX-32.1 9584
10 LOGO hska-20230331_g1.jpg GRAPHIC 53004
  Complete submission text file 0001038133-23-000023.txt   9439929

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hska-20230331.xsd EX-101.SCH 58803
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hska-20230331_cal.xml EX-101.CAL 108293
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hska-20230331_def.xml EX-101.DEF 353095
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hska-20230331_lab.xml EX-101.LAB 749686
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hska-20230331_pre.xml EX-101.PRE 512614
83 EXTRACTED XBRL INSTANCE DOCUMENT hska-20230331_htm.xml XML 1634577
Mailing Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538
Business Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538 9704937272
HESKA CORP (Filer) CIK: 0001038133 (see all company filings)

IRS No.: 770192527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22427 | Film No.: 23892486
SIC: 2835 In Vitro & In Vivo Diagnostic Substances